Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air

Abstract

BackgroundSeveral classifications of adult asthma patients using cluster analyses based on clinical and demographic information has resulted in clinical phenotypic clusters that do not address molecular mechanisms. Volatile organic compounds (VOC) in exhaled air are released during inflammation in response to oxidative stress as a result of activated leukocytes. VOC profiles in exhaled air could distinguish between asthma patients and healthy subjects. In this study, we aimed to classify new asthma endotypes by combining inflammatory mechanisms investigated by VOC profiles in exhaled air and clinical information of asthma patients.MethodsBreath samples were analyzed for VOC profiles by gas chromatography–mass spectrometry from asthma patients (n = 195) and healthy controls (n = 40). A total of 945 determined compounds were subjected to discriminant analysis to find those that could discriminate healthy from asthmatic subjects. 2-step cluster analysis based on clinical information and VOCs in exhaled air were used to form asthma endotypes.ResultsWe identified 16 VOCs, which could distinguish between healthy and asthma subjects with a sensitivity of 100% and a specificity of 91.1%. Cluster analysis based on VOCs in exhaled air and the clinical parameters FEV1, FEV1 change after 3 weeks of hospitalization, allergic sensitization, Junipers symptoms score and asthma medications resulted in the formation of 7 different asthma endotype clusters. We identified asthma clusters with different VOC profiles but similar clinical characteristics and endotypes with similar VOC profiles, but distinct clinical characteristics.ConclusionThis study demonstrates that both, clinical presentation of asthma and inflammatory mechanisms in the airways should be considered for classification of asthma subtypes.Electronic supplementary materialThe online version of this article (doi:10.1186/s12931-014-0136-8) contains supplementary material, which is available to authorized users.

Identification and prospective stability of electronic nose (eNose)–derived inflammatory phenotypes in patients with severe asthma

“…Specific analysis by GC-MS will then be necessary in order to unravel the identity of the combination of VOCs. Recent GC-MS studies have shown that asthma particularly features exhaled VOCs that are associated with lipid peroxidation and inflammatory phenotypes 21,57 , the distribution of which is likely to drive the distinction between the three clusters. Finally, given the nature of the project there is an inevitable influence of medication and smoking on top of endogenous biological mechanisms.…”

Asthma diagnosis using integrated analysis of eosinophil microRNAs

“…Asthma is a heterogeneous and chronic respiratory illness. Due to its diversity, it is complicated to diagnose correctly . Over time, many investigators have searched for biomarkers, preferably noninvasive ones such as miRNAs detected in easily available biofluids …”

Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project

“…Several putative asthma-related VOCs (and other commonly reported VOCs such as C5 to C15 alkanes, acetone, isoprene, toluene, and internal standards) [22][23][24][25][26][27] were targeted for further assessment, based on predicted retention indices (using cubic spline interpolation within a retention index error threshold of ± 20) and mass fragments (extracted from Pubchem and NIST online chemical databases). The identity of compounds that met these search criteria were then confirmed by pre-processing chromatograms using AMDIS (version 2.72) and subsequently NIST14 library search.…”